Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated

被引:27
作者
Legro, RS [1 ]
Urbanek, M [1 ]
Kunselman, AR [1 ]
Leiby, BE [1 ]
Dunaif, A [1 ]
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Obstet & Gynecol, Hershey, PA 17033 USA
基金
美国国家卫生研究院;
关键词
polycystic ovary syndrome; epidemiology; hyperandrogenism; dyslipidemia; hyperinsulinemia;
D O I
10.1016/S0015-0282(02)03153-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether self-selected women with polycystic ovary syndrome (PCOS) are abnormal compared with a control population. Design: Case-control. Setting: Support group meeting organized and initiated by patients. Patient(s): Forty-five self-selected women with PCOS and 80 control women. Intervention(s): Self-selected women with PCOS at a peer support conference completed a questionnaire, had a brief physical, and gave a fasting blood sample. Main Outcome Measure(s): Historical, biometric, and assay results. Result(s): Sixty percent of the women attending the conference participated in the study. Most had been diagnosed with PCOS on the basis of ovarian morphology (35%). They were more likely to be nulliparous and have a history of oligomenorrhea (96%). They were hyperandrogenemic (significantly elevated testosterone and DHEAS levels) compared with control women. Self-selected women with PCOS displayed multiple metabolic abnormalities compared with control women, including elevations in blood pressure, waist-hip ratio, fasting insulin, fasting total cholesterol, and fasting low-density lipoprotein cholesterol levels, as well as a significant decrease in fasting glucose-insulin ratio and high-density lipoprotein cholesterol levels. Conclusion(s): Self-selected women with PCOS have reproductive and metabolic abnormalities. The majority of these women received inadequate treatment despite having risk factors for endometrial cancer, diabetes, and/or heart disease. Our study also suggests that women attending or participating in a PCOS support group are willing and likely to participate in clinical studies. (C) 2002 by American Society for Reproductive Medicine.
引用
收藏
页码:51 / 57
页数:7
相关论文
共 33 条
[1]  
American Diabetes Association Clinical Practice Recommendations, 2001, DIABETES CARE S1, V24, pS1
[2]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[3]   A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].
Asunción, M ;
Calvo, RM ;
San Millán, JL ;
Sancho, J ;
Avila, S ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438
[4]   Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study [J].
Azziz, R ;
Hincapie, LA ;
Knochenhauer, ES ;
Dewailly, D ;
Fox, L ;
Boots, LR .
FERTILITY AND STERILITY, 1999, 72 (05) :915-925
[5]   Polycystic ovary syndrome and hyperprolactinemia [J].
Bracero, N ;
Zacur, HA .
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2001, 28 (01) :77-+
[6]   Diagnosis of polycystic ovary syndrome [J].
Chang, RJ ;
Katz, SE .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1999, 28 (02) :397-+
[7]  
COULAM CB, 1983, OBSTET GYNECOL, V61, P403
[8]   A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile [J].
Diamanti-Kandarakis, E ;
Kouli, CR ;
Bergiele, AT ;
Filandra, FA ;
Tsianateli, TC ;
Spina, GG ;
Zapanti, ED ;
Bartzis, MI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4006-4011
[9]   Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis [J].
Dunaif, A .
ENDOCRINE REVIEWS, 1997, 18 (06) :774-800
[10]   The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome [J].
Dunaif, A ;
Scott, D ;
Finegood, D ;
Quintana, B ;
Whitcomb, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3299-3306